Neopharmed Gentili S.p.A.
Neopharmed Gentili S.p.A.
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Topical Nifedipine 0.3% Plus Lidocaine 1.5% for Uncomplicated Hemorrhoidal Disease | Digestive System Diseases, cardiovascular disorder, digestive system disorder, hemorrhoid, intestinal disorder, rectal disorder, vascular disorder | Recruiting | Not stated | 2025-12-22 | NCT07295886 |